The Indoor Allergy Panel is a serum-based immunoassay panel that measures allergen-specific immunoglobulin E (IgE) antibodies directed against common indoor environmental allergens, typically including house dust mites (Dermatophagoides pteronyssinus and D. farinae), cockroach, cat dander, dog dander, and mold species such as Aspergillus and Alternaria. Elevated allergen-specific IgE levels indicate sensitization to one or more of these indoor antigens and are used to guide diagnosis and management of allergic rhinitis, allergic asthma, and atopic conditions. This panel is clinically important because indoor allergen sensitization is a major driver of perennial (year-round) allergic disease and can significantly impair quality of life. Upon initial allergen exposure in a genetically susceptible individual, antigen-presenting cells activate Th2 lymphocytes, which drive B-cell class switching to produce allergen-specific IgE antibodies; these IgE molecules bind to high-affinity FcεRI receptors on mast cells and basophils throughout mucosal tissues. On re-exposure to the same allergen, cross-linking of receptor-bound IgE triggers rapid degranulation and release of histamine, leukotrienes, prostaglandins, and cytokines, producing the immediate hypersensitivity response characteristic of allergic disease. Chronic allergen exposure perpetuates a late-phase inflammatory response involving eosinophils and additional Th2 cytokines (IL-4, IL-5, IL-13), contributing to airway remodeling and persistent symptoms.
This panel checks whether your immune system has developed an allergic response (IgE antibodies) to common indoor triggers like dust mites, pet dander, cockroaches, or molds. A positive result means your immune system recognizes these substances, which—combined with your symptoms—can help your doctor recommend targeted avoidance strategies or allergy treatments.
When elevated: Elevated allergen-specific IgE to one or more indoor allergens indicates immunologic sensitization and, when correlated with consistent symptoms upon exposure, supports a diagnosis of IgE-mediated allergic rhinitis, allergic asthma, or atopic dermatitis driven by indoor triggers. Higher class levels (Class 3 and above, ≥3.51 kU/L) are associated with greater likelihood of clinical reactivity and may predict more robust responses to allergen immunotherapy. Polysensitization (sensitization to multiple indoor allergens simultaneously) is associated with more severe and persistent allergic disease and greater treatment complexity. When low: Undetectable or very low allergen-specific IgE (Class 0) to all tested indoor allergens makes IgE-mediated allergy to those specific antigens unlikely and suggests that symptoms may be attributable to non-allergic rhinitis, vasomotor rhinitis, irritant exposures, or allergens not included in the panel. A negative panel result in a patient with strong clinical suspicion of indoor allergy should prompt consideration of expanded allergen testing, skin prick testing, or evaluation for local allergic rhinitis (entopy), in which IgE production is confined to nasal mucosa without systemic elevation. Very low total IgE states (e.g., in agammaglobulinemia) may also suppress specific IgE detectability.
Indoor allergen sensitization can impair training quality and recovery by triggering nasal congestion, airway inflammation, or asthma symptoms—particularly relevant for endurance athletes and those training indoors (gyms, pools, indoor tracks). Identifying specific indoor allergens allows targeted environmental control and symptom management, supporting consistent training volume and performance without unnecessary medication or avoidance strategies.
Turnaround Time
3 days (up to 7 days)
Fasting Required
No
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$270.00$810
3.0× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$270.00
Peer-reviewed sources supporting the educational content on this page.
